Selecta

Selecta Biosciences is a biotechnology company that develops and commercializes immunotherapies for the treatment of autoimmune diseases.

Business Model:

Revenue: $123.9M

Employees: 51-200

Detailed Selecta Information

Geographic Data

Selecta headquarters map

Address: 65 Grove Street

City: Watertown

State: MA

Zip: 02472

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$39M

Raised Total:

$320M

Metrics

3,584,443Website Global Rank

3,788Website Monthly Traffic

Twitter Followers

Description

Selecta Biosciences is a biotechnology company that develops and commercializes immunotherapies for the treatment of autoimmune diseases.

Contact Phone:
+16179231400

Contact Email:

Selecta went public on 6/22/2016 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/22/2016

IPO Valuation:
$249M

Ticker Symbol:
SELB

IPO Price:
$14/share

Amount Raised:
$70M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
12/2021 Cyrus Biotechnology Series B 0
12/2021 Cyrus Biotechnology Series B 0
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2014 Venture Round $5.3M
10/2011 Series D 1 $47.3M RUSNANO
RUSNANO
12/2019 Equity $70M ND Capital
Polaris Partners
8/2014 Venture Round $4.5M
8/2020 Debt $35M Oxford Finance LLC
Silicon Valley Bank
8/2019 Post-IPO Equity $5.8M
7/2020 Equity $25M
9/2020 Post-IPO Debt 2 $35M Silicon Valley Bank
Oxford Finance LLC
Silicon Valley Bank
Oxford Finance LLC
5/2008 Seed Round 2 $2.5M Polaris Venture Capital
Flagship Pioneering
Polaris Venture Capital
Flagship Pioneering
2/2012 Series D 1 $22M RUSNANO
RUSNANO
4/2010 Series C 5 $15M Polaris Partners
OrbiMed
NanoDimension
Leukon Investments
Flagship Pioneering
Polaris Partners
OrbiMed
NanoDimension
Leukon Investments
Flagship Pioneering
12/2016 Post-IPO Equity $5M
2/2009 Series B 4 $15.1M Timothy A. Springer
Polaris Partners
NanoDimension
Flagship Pioneering
Timothy A. Springer
Polaris Partners
NanoDimension
Flagship Pioneering
6/2014 Grant $8.1M
8/2010 Grant 1 $3M National Institutes of Health
National Institutes of Health
9/2015 Series E 14 $38M RUSNANO
Polaris Partners
Sanofi Ventures
Sphera Funds Management
Eminent Venture Capital
OUP (Osage University Partners)
Leukon Investments
I2BF Global Ventures
OrbiMed
Scott H. Cohen
Ridgeback Capital
NanoDimension
Polaris Partners
Sanofi Ventures
Sphera Funds Management
Eminent Venture Capital
OUP (Osage University Partners)
Leukon Investments
I2BF Global Ventures
OrbiMed
10/2014 Private Equity Round 8 $20M RUSNANO
Polaris Partners
OrbiMed
NanoDimension
Leukon Investments
I2BF Global Ventures
Flagship Pioneering
Eminent Venture Capital
4/2015 Venture Round $5.9M
4/2022 Post-IPO Equity $38.7M
8/2020 Post-IPO Equity $25M
9/2017 Post-IPO Equity 1 $21M OUP (Osage University Partners)
OUP (Osage University Partners)
12/2014 Grant 1 $3.2M Skolkovo Foundation
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research